Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sm14 Vaccine for Schistosomiasis in Senegalese School Children
NCT03799510Phase 2Completed
- Sponsor
- Fundação Oswaldo Cruz
- Start
- Dec 2018
- Primary completion
- Jul 2019
- Modality
- Split/Subunit Vaccines, Peptide-based Cancer Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of Sm14 in schistosomiasis, sponsored by Fundação Oswaldo Cruz. Started Dec 2018; status: completed.
02
Drugs
Sm14
03
Conditions
schistosomiasis
Beyond the preview
Go deeper on NCT03799510.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03799510.